Jorey Chernett, a 10% owner of Oncology Institute, Inc. (NASDAQ:TOI), executed a direct purchase of the company's common stock on July 10, 2026. The transaction involved the acquisition of 15,000 shares for a total value of $87,750. The shares were bought at prices ranging from $5.82 to $5.90 per share. The reported weighted average price for these transactions was $5.85 per share. The insider purchase comes as TOI trades near its 52-week high of $6.11, with the stock delivering an impressive 88% return over the past year. Following this direct purchase, Mr. Chernett now holds a total of 10,630,858 shares of Oncology Institute common stock. The company, valued at $598 million, has shown strong revenue growth of 35% over the last twelve months, though it remains unprofitable with an EPS of -$0.37.
Key Points:
- 10% shareholder Jorey Chernett acquired 15,000 shares at a weighted average price of $5.85, increasing his total stake to 10,630,858 shares.
- The Oncology Institute successfully refinanced $86 million in debt with OrbiMed, utilizing a new $75 million term loan maturing in 2031 and approximately $11 million in cash to repay a senior secured convertible note with Deerfield Partners.
- Analyst sentiment turned more positive, with BTIG raising its price target to $9, Lake Street initiating coverage with a $10 target, and Needham increasing its target to $7 following discussions with company executives.
Risks and Uncertainties:
- The company remains unprofitable with an EPS of -$0.37, highlighting ongoing financial challenges despite revenue growth.
- The refinancing transaction did not involve raising additional equity, potentially limiting immediate capital expansion options.
- Market volatility near the 52-week high of $6.11 could impact future trading performance despite recent positive developments.
These recent developments highlight the company's strategic moves and potential growth opportunities in the healthcare sector. The Oncology Institute's Chief Medical Officer, Yale D. Podnos, is set to speak at the APG Spring Conference in San Diego, discussing the role of specialists in value-based healthcare delivery. This engagement underscores the company's focus on expanding its influence within the specialty finance and healthcare delivery sectors.
InvestingPro offers 7 additional exclusive tips for TOI, plus comprehensive Pro Research Reports covering 1,400+ US stocks with expert analysis and actionable insights. ProPicks AI evaluates TOI every month against thousands of alternatives using 100+ financial metrics. It found Siemens Energy (+231.5%) and Sandisk (+189%) before the crowd did. Could TOI be next—or is there a better opportunity in the same space?